A fractal based model of diffusion MRI in cortical grey matter

Diffusion Weighted Magnetic Resonance (DWMR) Imaging is an important tool in diagnostic neuroimaging, but the biophysical basis of the DWMR signal from biological tissue is not entirely understood. Testable, theoretical models relating the DWMR signal to the tissue, therefore, are crucial. This work presents a toy version of such a model of water DWMR signals in brain grey matter. The model is based on biophysical characteristics and all model parameters are directly interpretable as biophysical properties such as diffusion coefficients and membrane permeability allowing comparison to known values. In the model, a computer generated Diffusion Limited Aggregation (DLA) cluster is used to describe the collected membrane morphology of the cells in cortical grey matter. Using credible values for all model parameters model output is compared to experimental DWMR data from normal human grey matter and it is found that this model does reproduce the observed signal. The model is then used for simulating the effect on the DWMR signal of cellular events known to occur in ischemia. These simulations show that a combination of effects is necessary to reproduce the signal changes observed in ischemic tissue and demonstrate that the model has potential for interpreting DWMR signal origins and tissue changes in ischemia. Further studies are required to validate these results and compare them with other modeling approaches. With such models, it is anticipated that sensitivity and specificity of DWMR in tissues can be improved, leading to better understanding of the origins of MR signals in biological tissues, and improved diagnostic capability

Characterizing the pre-clinical phase of inflammatory bowel disease

Understanding the biological changes that precede a diagnosis of inflammatory bowel disease (IBD) could facilitate pre-emptive interventions, including risk factor modification, but this pre-clinical phase of disease remains poorly characterized. Using measurements from 17 hematological and biochemical parameters taken up to 10 years before diagnosis in over 20,000 IBD patients and population controls, we address this at massive scale. We observe widespread significant changes in multiple biochemical and hematological parameters that occur up to 8 years before diagnosis of Crohn's disease (CD) and up to 3 years before diagnosis of ulcerative colitis. These changes far exceed previous expectations regarding the length of this pre-diagnostic phase, revealing an opportunity for earlier intervention, especially in CD. In summary, using a nationwide, case-control dataset-obtained from the Danish registers-we provide a comprehensive characterization of the hematological and biochemical changes that occur in the pre-clinical phase of IBD.</p